Neurodegenerative Disease Management
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.8 | Q2 | 52.0% | 0.804 | Q2 | 77.4% |
| 2024 | 3.4 | Q2 | 73.0% | 0.896 | Q2 | 81.3% |
| 2023 | 2.3 | Q3 | 55.4% | 0.618 | Q2 | 71.9% |
| 2022 | 2.6 | 52.0% | 0.518 | Q2 | 67.3% | |
| 2021 | — | 43.8% | 0.487 | Q3 | 66.3% | |
| 2020 | — | — | 0.674 | Q2 | 75.1% | |
| 2019 | — | — | 0.550 | Q2 | 70.1% | |
| 2018 | — | — | 0.632 | Q3 | 72.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1758-2032
ISSN
1758-2024
region
Western Europe
coverage
2014-2026